Senior PhD. Professor at Center for Molecular Immunology, Cuba.
Dr. Nuris Ledón-Naranjo is a Senior PhD Professor at the Center for Molecular Immunology, distinguished for her impactful contributions to biomedical sciences. With a biology degree earned with a Gold Medal, she advanced her expertise through MSc degrees in Biomedicine and Business Administration, and a Doctorate in Pharmaceutical Sciences. She has dedicated over three decades to groundbreaking research in immunosenescence, cancer, and inflammation. Dr. Ledón-Naranjo has led major national and international projects, authored over 50 peer-reviewed publications, and holds three patents. Her work has influenced both clinical applications and pharmaceutical innovation. She has received prestigious awards, including the National Health Award and the Carlos J. Finlay Order. Her extensive academic, scientific, and leadership record makes her an outstanding candidate for the Best Researcher Award.
🌍 Professional Profile:
Scopus
Orcid
🏆 Suitability for the Best Researcher Award
Dr. Nuris Ledón-Naranjo exemplifies excellence in biomedical research, making her a prime candidate for the Best Researcher Award. With a distinguished academic background and over three decades of professional experience, she has significantly advanced the fields of immunology, oncology, and inflammation research. Her leadership in developing biological drugs, coordinating clinical trials, and technology transfer projects has greatly impacted healthcare innovation. Dr. Ledón-Naranjo’s contributions include over 50 international publications, several patents, and acclaimed projects on biopharmaceuticals and immunosenescence. Recognized nationally and internationally with awards such as the National Health Award and the Carlos J. Finlay Order, she demonstrates an unwavering commitment to scientific advancement and translational medicine, inspiring the next generation of researchers through her mentorship and pioneering work.
🎓 Education
Dr. Nuris Ledón-Naranjo pursued her academic journey with excellence, earning her degree in Biology with a Gold Medal in 1992. She subsequently completed her Master’s degree in Biomedicine in 1996, demonstrating a strong commitment to biomedical research. Recognizing the importance of integrating science with management, she earned an MSc in Business Administration in 2016. Her highest academic achievement came with the Doctorate in Pharmaceutical Sciences in 2000. Throughout her academic career, Dr. Ledón-Naranjo has combined rigorous scientific study with leadership and innovation, equipping herself with interdisciplinary skills crucial for scientific advancement. Her education has laid a robust foundation for her contributions to molecular immunology, drug development, and translational medicine.
🏢 Work Experience
Dr. Nuris Ledón-Naranjo has accumulated over 30 years of professional experience in biomedical research and education. She began her scientific career at CNIC (1992–2002), working on key projects related to immunology and toxicology. Since 2003, she has served at the Center for Molecular Immunology (CIM), specializing in drug development for cancer and inflammatory diseases. She also contributed academically as an adjunct professor at ISPEJV University (2000–2009) and the University of Havana (2017–present). Her work spans directing clinical trials, coordinating drug registration efforts, and transferring technologies nationally and internationally. Dr. Ledón-Naranjo’s experience blends laboratory excellence, project leadership, and educational mentorship, contributing significantly to the advancement of molecular and clinical immunology.
🏅 Awards and Honors
Dr. Nuris Ledón-Naranjo’s outstanding contributions have been recognized through numerous awards and honors. She received the National Health Award and the Academy of Sciences Award for her innovative biomedical research. Her exceptional achievements in science and public health were crowned by the prestigious Carlos J. Finlay Order, a national honor awarded to eminent scientists. Beyond these, she has been acknowledged at both national and international levels for her work in drug development, clinical research, and scientific innovation. These awards reflect not only her scientific excellence but also her societal impact through medical advancements. Her recognition underscores her enduring commitment to research excellence and her influential role in the field of immunology and pharmaceutical sciences.
🔬 Research Focus
Dr. Nuris Ledón-Naranjo’s research focus spans immunosenescence, cancer, and inflammation, aiming to develop innovative therapeutic approaches. Her projects include the biochemical and pharmacological characterization of natural products for inflammatory diseases and cancer, emphasizing mechanisms of action and clinical application. She has led studies on recombinant biotechnological products like erythropoietin and monoclonal antibodies targeting HER2, CD20, PD-1, and IL-6. Her work also covers antioxidant and hypolipidemic drug development, immunological markers, and aging-related inflammation. Furthermore, she has directed technology transfers for drug potency assays to national and international institutions. Through her integrated approach, Dr. Ledón-Naranjo bridges laboratory research and clinical practice, pushing the boundaries of molecular immunology and therapeutic innovation.
📊 Publication Top Notes:
Claro I., González C., Domínguez C., Hernández C., Illistegui P., Alvarez A., Ledón N. (1994). Efecto de la Ciclosporina sobre el páncreas endocrino: Aspectos morfológicos y funcionales. Bioquimia, XIX, 80–90.
• Ledón N., Claro A., Domínguez C. (1996). Efectos combinados de la CsA y el verapamilo en las células pancreáticas. Revista Cubana de Farmacia, 2, 95–99.
• Ledón N., Casacó A., González R., Merino N., González A., Tolón Z. (1996). Efectos farmacológicos de un extracto de propóleo rojo cubano. Revista Cubana de Farmacia, 1, 36–42.
• Ledón N., Casacó A., González R., Merino N., González A., Tolón Z. (1997). Antipsoriatic, anti-inflammatory and analgesic effects of propolis collected in Cuba. Acta Pharmacologica Sinica, 18, 274–276.
• Romay C., Armesto J., Remirez D., González R., Ledón N., García I. (1998). Antioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae. Inflammation Research, 47(1), 36–41.
• Romay C., Ledón N., González R. (1998). Further studies on anti-inflammatory activity of phycocyanin in some animal models of inflammation. Inflammation Research, 47(8), 334–338.
• Casacó A., Ledón N., González A., Merino N., Pérez R. (1999). Topical anti-inflammatory activity of human recombinant epidermal growth factor. Skin Pharmacology and Applied Skin Physiology, 12(1-2), 79–84.
• Romay C., Ledón N., González R. (1999). Phycocyanin extract reduces leukotriene B4 levels in arachidonic acid-induced mouse-ear inflammation test. Journal of Pharmacy and Pharmacology, 51(5), 641–642.
• Romay C., Ledón N., González R. (2000). Effects of phycocyanin extract on prostaglandin E2 levels in mouse ear inflammation test. Arzneimittelforschung, 50(12), 1106–1109.